Hyloris Sets Out Plans To Expand Its Pipeline

Value Added Medicines Company Aims For 14 Commercial Products By 2024

After partnering with companies like Purna Female Healthcare and AFT Pharmaceuticals, Belgian value-added medicines specialist Hyloris has announced plans to add three new products to its pipeline in the coming months with a goal of having 14 commercial products by 2024. 

expansion
Hyloris reveals plans to add at least three products to its pipeline in 2021 and commercialize 14 products by 2024 • Source: Shutterstock

ForHyloris Pharmaceuticals SA, 2021 began with pipeline expansion as the company entered into a partnership with Purna Female Healthcare. And the Belgian value-added medicines specialist has revealed that it further plans to expand its pipeline with at least three new products in the coming months.

Furthermore, the company said that it was on track to fuel the pipeline with at least four new product candidates in 2021, with a longer-term

More from Earnings

More from Business